Transgenic mice reveal roles for TGFα and EGF receptor in mammary gland development and neoplasia

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 2, 1997, Pages 119-129

  Schroeder, Joyce A ^a   Lee, David C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

EGFR; Mammary gland; Neoplasia; TGF ; Transgenic mice

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; REVIEW; TRANSGENIC MOUSE; UDDER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031107207     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026347629876     Document Type: Article

References (64)

1. D. C. Lee, S. E. Fenton, E. A. Berkowitz, and M. A. Hissong (1995). Transforming growth factor α: expression, regulation, and biological activities. Pharmacol. Rev. 47:51-85.
2. N. C. Luetteke, T. H. Qiu, R. L. Peiffer, P. Oliver, O. Smithies, and D. C. Lee (1993). TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278.
3. G. B. Mann, K. J. Fowler, A. Gabriel, E. C. Nice, R. L. Williams, and A. R. Dunn (1993). Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261.
4. E. A. Berkowitz, K. B. Seroogy, J. A. Schroeder, W. E. Russell, E. P. Evans, R. F. Riedel, H. K. Phillips, C. A. Harrison, D. C. Lee, and N. C. Luetteke (1996). Characterization of the mouse transforming growth factor α gene: its expression during eyelid development and in waved I tissues. Cell Growth Diff. 7:1271-1282.
5. L. Panico, A. D'Antonio, G. Salvatore, E. Mezza, G. Tortora, M. D. Laurentiis, S. D. Placido, T. Giordano, M. Merino, D. S. Salomon, W. J. Mullick, G. Pettinato, S. J. Schnitt, A. R. Bianco, and F. Ciardiello (1996). Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int. J. Cancer. 65:51-56.
6. R. B. Dickson, M. D. Johnson, M. Bano, E. Shi, J. Kurebayashi, B. Ziff, I. Martinez-Lacaci, L. T. Amundadoltir, and M. E. Lippman (1992). Growth factors in breast cancer: mitogenesis to transformation. J. Steroid Blochem. Mol. Biol. 43:69-78.
7. K. Stromberg, M. Duffy, C. Fritsch, W. R. Hudgins, E. S. Sharp, L. D. Murphy, M. E. Lippman, and S. E. Bates (1991). Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women. Cancer Det. Prev. 15:277-283.
8. S. C. Liu, B. Sanfillipo, I. Perroteau, R. Derynck, D. S. Salomon, and W. R. Kidwell (1987). Expression of transforming growth factor α (TGFα) in differentiated rat mammary tumors: estrogen induction of TGFα production. Mol. Endocrinol. 1:683-692.
9. S. E. Bates, N. E. Davidson, E. M. Valverius, C. E. Freter, R. B. Dickson, J. P. Tam, J. E. Kudlow, M. E. Lippman, and D. S. Salomon (1988). Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol. 2:543-555.
10. C. L. Arteaga, E. Coronado, and C. K. Osborne (1988). Blockade of the epidermal growth factor receptor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer. Mol. Endocrinol. 2:1064-1069.
11. M. L. McGeady, S. Kerby, V. Shankar, F. Ciardiello, D. Salomon, and M. Seidman (1989). Infection with a TGF-α retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. Oncogene 4:1375-1382.
12. A. Rosenthal, P. B. Lindquist, T. S. Bringman, D. V. Goeddel, and R. Derynck (1986). Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation. Cell 46:301-309.
13. E. P. Sandgren, N. C. Luetteke, R. D. Palmiter, R. L. Brinster, and D. C. Lee (1990). Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135.
14. C. Jhappan, C. Stahle, R. N. Harkins, N. Fausto, G. H. Smith, and G. T. Merlino (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146.
15. P. J. Dempsey, J. R. Goldenring, C. J. Soroka, I. M. Modlin, R. W. McClure, C. D. Lind, A. D. Ahlquist, M. R. Pittelkow, D. C. Lee, E. P. Sandgren, D. L. Page, and R. J. Coffey (1992). Possible role of transforming growth factor α in the patholgenesis of Menetrier's disease: supportive evidence from humans and transgenic mice. Gastroenterology. 103:1950-1963.
16. H. Takagi, C. Jhappan, R. Sharp, and G. Merlino (1992). Hypertrophic gastropathy resembling menetrier's disease in transgenic mice overexpressing transforming growth factor α in the stomach. J. Clin. Invest. 90:1161-1167.
17. Y. Matsui, S. A. Halter, J. T. Holt, B. L. M. Hogan, and R. J. Coffey (1990). Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61:1147-1155.
18. S. A. Halter, P. Dempsey, Y. Matsui, M. K. Stokes, R. Graves-Deal, B. L. Hogan, and R. J. Coffey (1992). Distinctive patterns of hyperplasia in transgenic mice with mouse mammary virus transforming growth factor-α. Amer J. Path. 140:1131-1146.
19. E. P. Sandgren, J. A. Schroeder, T. H. Qui, R. D. Palmiter, R. L. Brinster, and D. C. Lee (1995). Inhibition of mammary gland involution is associated with transforming growth factor α but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 55:3915-3927.
20. R. A. McKnight, T. Burdon, V. G. Pursel, A. Shamay, R. J. Wall, and L. Hennighausen (1991). Genes, oncogenes, and hormones: advances in cellular and molecular biology of breast cancer, In The Whey Acidic Protein. R. B. Dickson and M. E. Lippman, (eds.), Kluwer Academic Publishers, Boston, pp 399-412.
21. G. H. Smith, R. Sharp, E. C. Kordon, C. Jhappan, and G. Merlino (1995). Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol. 147:1081-1096.
22. M. Hollstein, D. Sidransky, B. Vogelstein, and C. Harris (1991). p53 mutations in human cancers. Washington D.C. Science 253:49-53.
23. 1 phase of the cell cycle. Cell 65:701-713.
24. C. L. Rosenberg, T. Motokura, H. M. Kronenberg, and A. Arnold (1993). Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cylin D1 in two primary human tumors. Oncogene 8:519-521.
25. E. Schuuring, E. Verhoeven, W. J. Mooi, and R. J. Michalides (1992). Identification and cloning of two overexpressed genes, U21B3/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361.
26. C. Gillet, V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters (1994). Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1812-1817.
27. W. Jiang, S. M. Kahn, N. Tomita, Y.-J. Zhang, S.-H. Lu, and I. B. Weinstein (1992). Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52:2980-2983.
28. T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. (London) Nature 369:669-671.
29. A. Philipp, A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers (1994). Repression of cyclin D1: a novel function of myc. Mol. Cell. Biol. 14:4032-4043.
30. L. T. Amundadottir, M. D. Johnson, G. Merlino, G. H. Smith, and R. B. Dickson (1995). Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Diff. 6:737-748.
31. S. Sakai, M. Mizuno, T. Harigaya, K. Yamamoto, T. Mori, R. J. Coffey, and H. Nagasawa (1994). Cause of failure of lactation in mouse mammary tumor virus/human transforming growth factor α transgenic mice. Proc. Soc. Exp. Biol. Med. 205:236-242.
32. R. Strange, G. Li, S. Saure, A. Burkhardt, and R. R. Friis (1992). Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development 115:49-58.
33. D. Medina (1982). The mouse in biomedical research: experimental biology and oncology. In H. L. Foster, J. D. Small, and J. G. Fox, (eds.) Academic Press, New York, pp. 373-396.
34. M. Reiss, E. B. Stash, V. F. Vellucci, and Z.-L. Zhou (1991). Activation of the autocrine transforming growth factor α pathway in human squamous carcinoma cells. Cancer Res. 51:6254-6262.
35. E. Finzi, T. Ho, G. Anhalt, W. Hawkins, R. Harkins, and T. Horn (1992). Localization of transforming growth factor-α in human appendageal tumors. Am. J. Pathol. 141:643-653.
36. C. Liu, M.-S. Tsao, and J. W. Grisham (1988). Transforming growth factors produced by normal and neoplastically transformed rat liver epithelia cells in culture. Cancer Res. 48:850-855.
37. C. Liu, A. Woo, and M.-S. Tsao (1990). Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br. J. Cancer 62:425-429.
38. J. W. Grisham, M.-S. Tsao, D. C. Lee, and H. S. Earp (1990). Sequential changes in epidermal growth factor receptor/ligand function in cultured rat liver epithelial cells transformed chemically in vitro. Pathobiology 58:3-14.
39. L. W. Lee, V. W. Raymond, M.-S. Tsao, D. C. Lee, H. S. Earp, and J. W. Grisham (1991). Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor-α genes in chemically transformed rat liver epithelial cells. Cancer Res. 51:5238-5244.
40. S. Tanaka, K. Imanishi, M. Yoshihara, K. Haruma, K. Sumii, G. Kajiyama, and S. Akamatsu (1991). Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. Am. J. Pathol. 139:123-129.
41. R. J. Coffey Jr., K. S. Meise, Y. Matsui, B. L. M. Hogan, P. J. Dempsey, and S. A. Halter (1994). Acceleration of mammary neoplasia in transforming growth factor α transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res. 54:1678-1683.
42. W. E. Russell, W. K. Kaufmann, S. Sitaric, N. C. Luetteke, and D. C. Lee (1996). Liver regeneration and hepatocarcinogenesis in transforming growth factor-α-targeted mice. Mol. Carcin. 15:183-189.
43. J. M. Varley, J. E. Swallow, W. J. Brammar, J. L. Whittaker, and R. A. Walker (1987). Alterations to eithr c-erbB-2(neu) or c-myc and proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1:423-430.
44. R. B. Dickson, A. Kasid, K. K. Huff, S. E. Bates, C. Knabbe, D. Bronzen, E. P. Gelmann, and M. E. Lippman (1987). Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. U.S.A. 84:837-841.
45. R. B. Dickson, K. K. Huff, E. M. Spencer, and M. E. Lippman (1986). Induction of epidermal growth factor-related polypeptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology 118:138-142.
46. S. E. Bates, M. E. McManaway, M. E. Lippman, and R. B. Dickson (1986). Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 46:1707-1713.
47. D. Dubik, T. C. Dembinski, and R. P. C. Shiu (1987). Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cell. Cancer Res. 47:6517-6521.
48. D. Dubik and R. P. C. Shiu (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263:12705-12708.
49. E. P. Sandgren, N. C. Luetteke, T. H. Qiu, R. D. Palmiter, R. L. Brinster, and D. C. Lee (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol. 13:320-330.
50. C. R. King, M. H. Kraus, and S. A. Aaronson (1985). Amplification of a novel v-erbB related gene in human mammary carcinoma. Science 229:974-976.
51. D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire (1987). Human breast cancer: correlation of relapse and survival with amplification of Her-2/neu oncogene. Science 235:177-182.
52. M. van de Vijver, R. van de Bersselaar, P. Devilee, C. Cornelisse, J. Peterse, and R. Nusse (1987). Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatevely frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell Biol. 7:2019-2023.
53. W. J. Gullick, S. B. Love, C. Wright, D. M. Barnes, B. Gutterson, A. L. Harris, and D. G. Altman (1991). c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer. 63:434-438.
54. M. C. Paterson, K. D. Dietrich, J. Danyluk, A. H. Paterson, A. W. Lees, N. Jamil, J. Hanson, H. Jenkins, B. E. Krause, W. A. McBlain, D. J. Slamon, and R. M. Fourney (1991). Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51:556-567.
55. E. Tzahar, H. Waterman, X. Chen, G. Levkowitz, D. Karunagaran, S. Lavi, B. J. Ratzkin, and Y. Yarden (1996). A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 16:5276-5287.
56. W. J. Muller, E. Sinn, R. Wallace, P. K. Pattengale, and P. Leder (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
57. L. Bouchard, L. Lamarre, P. J. Tremblay, and P. Jolicoeur (1989). Stochastic appearance of mammary tumors in transgenic mice carrying the activated c-neu oncogene. Cell 57:931-936.
58. C. T. Guy, M. A. Webster, M. Schaller, T. J. Parson, R. D. Cardiff, and W. J. Muller (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U.S.A. 89:10578-10582.
59. P. M. Siegel, D. L. Dankort, W. R. Hardy, and W. J. Muller (1994). Novel acting mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell Biol. 14:7068-7077.
60. W. J. Muller, C. L. Arteaga, S. K. Muthuswamy, P. M. Siegel, M. A. Webster, R. D. Cardiff, K. S. Meise, F. Li, S. A. Halter, and R. J. Coffey (1996). Synergistic interaction of the neu proto-oncogene product and transforming growth factor α in the mammary epithelium of transgenic mice. Mol. Cell Biol. 16:5726-5736.
61. D. S. Liscia, G. Merlo, F. Ciardello, N. Kim, G. H. Smith, R. Callahan, and D. S. Salomon (1990). Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Develop Biol. 140:123-131.
62. S. M. Snedeker, C. F. Brown, and R. P. Augustine (1991). Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88:8167-8171.
63. N. C. Luetteke, H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee (1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes and Dev. 8:263-278.
64. K. J. Fowler, F. Walker, W. Alexander, M. L. Hibbs, E. C. Nice, R. M. Bohmer, G. B. Mann, C. Thumwood, R. Maglitto, J. A. Danks, R. Chetty, A. W. Burgess, and A. R. Dunn (1995). A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. U.S.A. 92:1465-1469.